Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1α and β

Journal of Immunology

Volumn 169, Issue 8, 2002, Pages 4522-4530

  Lin, Tong Jun ^a   Garduno, Rafael ^a   Boudreau, Robert T M ^a   Issekutz, Andrew C ^a  

^a IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; CD18 ANTIGEN; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0037108528     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.8.4522     Document Type: Article

References (52)

1. Koch, C., and N. Hoiby. 1993. Pathogenesis of cystic fibrosis. Lancet 341:1065.
2. Cross, A., J. R. Allen, J. Burke, G. Ducel, A. Harris, J. John, D. Johnson, M. Lew, B. MacMillan, P. Meers, et al. 1983. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev. Infect. Dis. 5 (Suppl. 5):S837.
3. Berger, M. 1991. Inflammation in the lung in cystic fibrosis: a vicious cycle that does more harm than good? Clin. Rev. Allergy 9:119.
4. Cripps, A. W., M. L. Dunkley, R. L. Clancy, and J. Kyd. 1995. Pulmonary immunity to Pseudomonas aeruginosa. Immunol. Cell Biol. 73:418.
5. Wagner, J. G., and R. A. Roth. 2000. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol. Rev. 52:349.
6. Doerschuk, C. M., R. K. Winn, H. O. Coxson, and J. M. Harlan. 1990. CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J. Immunol. 144:2327.
7. Ramamoorthy, C., S. S. Sasaki, D. L. Su, S. R. Sharar, J. M. Harlan, and R. K. Winn. 1997. CD18 adhesion blockade decreases bacterial clearance and neutrophil recruitment after intrapulmonary E. coli, but not after S. aureus. J. Leukocyte Biol. 61:167.
8. Dinarello, C. A., and S. M. Wolff. 1993. The role of interleukin-1 in disease. N. Engl. J. Med. 328:106
9. Kernacki, K. A., D. J. Goebel, M. S. Poosch, and L. D. Hazlett. 1998. Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice. Infect. Immun. 66:376.
10. Cheung, D. O., K. Halsey, and D. P. Speert. 2000. Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect. Immun. 68:4585.
11. Echtenacher, B., D. N. Mannel, and L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75.
12. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381:77.
13. Wershil, B. K., Z. S. Wang, J. R. Gordon, and S. J. Galli. 1991. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J. Clin. Invest. 87:446.
14. Galli, S. J. 1990. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62:5.
15. Lin, T. J., and A. D. Befus. 1999. Mast cells and eosinophils in mucosal defenses and pathogenesis. In Mucosal Immunology. P. L. Ogara, J. Mectecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock, eds. Academic Press, San Diego. p. 469.
16. Lin, T. J., T. B. Issekutz, and J. S. Marshall. 2000. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1α. J. Immunol. 165:211.
17. Boudreau, R. T., R. Garduno, and T. J. Lin. 2002. Protein phosphatase 2A and protein kinase Cα are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells. J. Biol. Chem. 277:5322.
18. Kamath, S., V. Kapatral, and A. M. Chakrabarty. 1998. Cellular function of elastase in Pseudomonas aeruginosa: role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis. Mol. Microbiol. 30:933.
19. + Escherichia coli by the human mast cell line (HMC-1 5C6) involves protein kinase C. J. Leukocyte Biol. 66:1031.
20. Issekutz, A. C., and N. Lopes. 1993. Endotoxin activation of endothelium for polymorphonuclear leukocyte transendothelial migration and modulation by interferon-γ. Immunology 79:600.
21. Issekutz, A. C., D. Rowter, and T. A. Springer. 1999. Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration. J. Leukocyte Biol. 65:117.
22. Desch, C, E., A. Dobrina, B. B. Aggarwal, and J. M. Harlan. 1990. Tumor necrosis factor-α exhibits greater proinflammatory activity than lymphotoxin in vitro. Blood 75:2030.
23. Smith, C. W., R. Rothlein, B. J. Hughes, M. M. Mariscalco, H. E. Rudloff, F. C. Schmalstieg, and D. C. Anderson. 1988. Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelial migration. J. Clin. Invest. 82:1746.
24. Mitsui, H., T. Furitsu, A. M. Dvorak, A. M. Irani, L. B. Schwartz, N. Inagaki, M. Takei, K. Ishizaka, K. M. Zsebo, S. Gillis, et al. 1993. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand, Proc. Natl. Acad. Sci. USA 90:735.
25. Song, Z, J., H. K. Johansen, V. Faber, and N. Hoiby. 1997. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS 105:438.
26. Song, Z., H. K. Johansen, V. Faber, C. Moser, A. Kharazmi, J. Rygaard, and N. Hoiby. 1997. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob. Agents Chemother. 41:961.
27. Lorentz A., S. Schwengberg, G. Sellge, M. P., Manns, S. C. Bischoff, 2000. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J. Immunol. 164:43
28. Woolley, D. E., and L. C. Tetlow. 2000. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res. 2:65.
29. Friedl, P., B. Konig, and W. Konig. 1992. Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells. Immunology 76:86.
30. Bergmann, U., J. Scheffer, M. Koller, W. Schonfeld, G. Erbs, F. E. Muller, and W. Konig. 1989. Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect. Immun. 57:2187.
31. Bischoff, S. C., A. Lorentz, S. Schwengberg, G. Weier, R. Raab, and M. P. Manns. 1999. Mast cells are an important cellular source of tumor necrosis factor α in human intestinal tissue. Gut 44:643.
32. Arock, M., E. Ross, R. Lai-Kuen, G. Averlant, Z. Gao, and S. N. Abraham. 1998. Phagocytic and tumor necrosis factor α response of human mast cells following exposure to Gram-negative and Gram-positive bacteria. Infect. Immun. 66:6030.
33. Rudner, X. L., K. A. Kernacki, R. P. Barrett, and L. D. Hazlett. 2000. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J. Immunol. 164:6576.
34. Schultz, M. J., A. W. Rijneveld, S. Florquin, C. K. Edwards, C. A. Dinarello, and T. van der Poll. 2002. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L285.
35. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443.
36. Supajatura, V., H. Ushio, A. Nakao, S. Akira, K. Okumura, C. Ra, and H. Ogawa. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109:1351.
37. Kotovuori, P., E. Tontti, R. Pigott, M. Shepherd, M. Kiso, A. Hasegawa, R. Renkonen, P. Nortamo, D. C. Altieri, and C. G. Gahmberg. 1993. The vascular E-selectin binds to the leukocyte integrins CD11/CD18. Glycobiology 3:131.
38. Luscinskas, F. W., M. I. Cybulsky, J. M. Kiely, C. S. Peckins, V. M. Davis, and M. A. Gimbrone, Jr. 1991. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J. Immunol. 146:1617.
39. Qin, L., W. M. Quinlan, N. A. Doyle, L. Graham, J. E. Sligh, F. Takei, A. L. Beaudet, and C. M. Doerschuk. 1996. The roles of CD11/CD18 and ICAM-1 in acute Pseudomonas aeruginosa-induced pneumonia in mice. J. Immunol. 157:5016.
40. Mizgerd, J. P., B. H. Horwitz, H. C. Quillen, M. L. Scott, and C. M. Doerschuk. 1999. Effects of CD18 deficiency on the emigration of murine neutrophils during pneumonia. J. Immunol. 163:995.
41. Kumasaka, T., N. A. Doyle, W. M. Quinlan, L. Graham, and C. M. Doerschuk. 1996. Role of CD11/CD18 in neutrophil emigration during acute and recurrent Pseudomonas aeruginosa-induced pneumonia in rabbits. Am. J. Pathol. 148:1297.
42. Satoh, S., K. Oishi, A. Iwagaki, M. Senba, T. Akaike, M. Akiyama, N. Mukaida, K. M. Atsushima, and T. Nagatake. 2001. Dexamethasone impairs pulmonary defense against Pseudomonas aeruginosa through suppressing iNOS gene expression and peroxynitrite production in mice. Clin. Exp. Immunol. 126:266.
43. Sawa, T., D. B. Corry, M. A. Gropper, M. Ohara, K. Kurahashi, and J. P. Wiener-Kronish. 1997. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J, Immunol. 159:2858.
44. Steinhauser, M. L., C. M. Hogaboam, S. L. Kunkel, N. W. Lukacs, R. M. Strieter, and T. J, Standiford. 1999. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 162:392.
45. Chmiel, J. F., M. W. Konstan, J. E. Knesebeck, J. B. Hilliard, T. L. Bonfield, D. V. Dawson, and M. Berger. 1999. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. Am. J. Respir. Crit. Care Med. 160:2040.
46. Auerbach, H. S., M. Williams, J. A. Kirkpatrick, and H. R. Colten. 1985. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 2:686.
47. Brunetti, M., A. Colasante, N. Mascetra, M. Piantelli, P. Musiani, and F. B. Aiello. 1998. IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation, J. Pharmacol. Exp. Ther. 285:915.
48. Fernandez-Morata, J. C., J. Mullol, M. Fuentes, L. Pujols, J. Roca-Ferrer, M. Perez, A. Xaubet, and C. Picado. 2000. Regulation of cyclooxygenase-1 and -2 expression in human nasal mucosa: effects of cytokines and dexamethasone. Clin. Exp. Allergy 30:1275.
49. Finotto, S., Y. Mekori, and D. Metcalfe. 1997. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand. stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J. Clin. Invest. 99:1721.
50. Jaffe, A., and I. M. Balfour-Lynn. 2002. Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids. Paediatr. Drugs 4:381.
51. Cohen, S., E. Hurd, J. Cush, M. Schiff, M. E, Weinblatt, L. W. Moreland, J. Kremer, M. B. Bear, W. J. Rich, and D. McCabe. 2002. Treatment of rheumatoid arthritis with anakinra, a recombinant human interieukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 46:614.
52. Greally, P., M. J. Hussain, D. Vergani, and J. F. Price. 1994. Interleukin-1α, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone. Arch. Dis. Child, 71:35.